Graves' Disease: In Silico Design of Hybrid Molecule Targeting the Thyroid-stimulating Hormone Receptor

Author:

Andrade Luís Jesuino de Oliveira1ORCID,de Oliveira Luís Matos2ORCID,Silva Catharina Peixoto2ORCID,de Oliveira Luísa Correia Matos3ORCID,David Túlio Matos4ORCID,Bittencourt Alcina Maria Vinhaes4ORCID,de Oliveira Gabriela Correia Matos5ORCID

Affiliation:

1. Department of Health Sciences, Santa Cruz State University, Ilhéus, Bahia, Brazil

2. Bahiana School of Medicine and Public Health - Salvador - Bahia - Brazil.

3. SENAI CIMATEC University Center – Salvador – Bahia - Brazil.

4. Federal University of Bahia School of Medicine – Salvador – Bahia – Brazil.

5. Medical Doctor, UniFTC Medical School - Salvador - Bahia - Brazil.

Abstract

Abstract Introduction Graves' disease (GD), an autoimmune disorder characterized by hyperthyroidism and the production of autoantibodies targeting the thyroid-stimulating hormone receptor (TSHR), poses a considerable challenge in clinical management. Antithyroid medications block thyroid hormone synthesis and are usually the first-line treatment. In recent years, the advent of computational molecule design has offered a promising avenue for the development of novel therapeutic strategies tailored to specific molecular targets. Despite the substantial progress made in silico molecule design for targeting the TSHR in GD, several critical gaps persist in the current literature. Objective To provide an in silico design of hybrid molecule targeting the TSHR. Method In silico hybridization of rituximab (RTX) and methimazole (MMZ) was performed through a comprehensive workflow: structural bioinformatics analysis, virtual screening and hybrid molecule design, molecular dynamics simulations, machine learning-based analysis, pharmacokinetic modeling and safety assessment, free energy calculations, in silico mutation analysis, data analysis and visualization. Result In silico approach identified a novel hybrid molecule candidate with promising potential for the treatment of GD. The designed molecule exhibited favorable characteristics in terms of binding affinity, selectivity, absorption, distribution, metabolism, excretion and toxicity profiles, and potential safety. Conclusion The designed molecule, derived from MMZ and RTX, exhibited promising characteristics in silico. The hybrid molecule demonstrated favorable binding affinity and selectivity towards the TSHR through virtual screening and molecular dynamics simulations.

Publisher

Research Square Platform LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3